Oral Abstract Sessions on Tuesday Afternoon

Date:October 21, 2014

Time:4:15 pm - 6:15 pm

Location:Hawaii Convention Center

OR02-01 HCC307 REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY FELLOWS RESEARCH II

4:15 PM O-117 ANESTHETIC AND ANALGESIC AGENTS USED DURING OOCYTE RETRIEVAL AND IN VITRO FERTILIZATION OUTCOME. Anatte Karmon

4:30 PM O-118 TRANSFORMING GROWTH FACTOR-β1 (TGF-β1) AND FIBROBLAST GROWTH FACTOR-7 (FGF-7) ELEVATED IN OVARIES OF SELECTIVE THECA CELL PHOSPHATASE AND TENSIN HOMOLOG MUTANT (tPtenMT) MICE WITH PCOS-LIKE PHENOTYPE. Shawn Redding

4:45 PM O-119 PROGRESSIVE FIBROSIS IN ENDOMETRIOSIS IS EPIGENETICALLY MEDIATED BY THE UBIQUITOUS CYTOKINE TGF-BETA VIA TRANSCRIPTION FACTOR KLF11. Luiz Correa

5:00 PM O-120 DONOR TSH LEVEL IS ASSOCIATED WITH IN VITRO FERTILIZATION OUTCOME AMONG OOCYTE DONATION CYCLES. Anatte Karmon

5:15 PM O-121 SUPEROVULATION DOES NOT INCREASE EMBRYONIC ANEUPLOIDY: A PROSPECTIVE EVALUATION OF ANEUPLOIDY IN NATURAL IVF CYCLES WITH COMPARISON TO 15,169 EMBRYOS FROM AGE CONTROLLED PEERS WHO HAD SUPEROVULATION. Kathleen Hong

5:30 PM O-122 IMPORT AND EXPORT OF FROZEN DONOR OOCYTE BANK: DOES TRANSPORTATION AFFECT SURVIVAL AND PREGNANCY RATES? Jeris Cox

5:45 PM O-123 INFERTILITY AND THE INTERNET: ETHICAL CONCERNS IN MEDICAL MARKETING. Jessica Chan

6:00 PM O-124 MODIFIABLE ASPECTS OF ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROCEDURES LEAD TO ALTERATIONS IN PLACENTAL DNA METHYLATION. Rachel Weinerman

OR02-02 HCC305 MENOPAUSE

4:15 PM O-125 FOLLICULAR DEVELOPMENT IS DEPENDENT ON AGE RATHER THAN OVARIAN RESERVE IN FEMALE CANCER SURVIVORS. Lauren Johnson

4:30 PM O-126 WITHIN-WOMAN VARIABILITY IN EARLY FOLLICULAR PHASE FOLLICLE STIMULATING HORMONE (FSH) IS ASSOCIATED WITH MODERATE/SEVERE HOT FLASHES IN THE MENOPAUSE TRANSITION. Mary Sammel

4:45 PM O-127 RISK FACTORS FOR FALLS IN A LONGITUDINAL COHORT STUDY OF SAUDI POSTMENOPAUSAL WOMEN: THE CEOR STUDY. Abdulrahim Rouzi

5:00 PM O-128 MEDICAL SPECIALTY AFFECTS WHEN AND WHY WOMEN ARE PRESCRIBED MENOPAUSAL HORMONE THERAPY. Cheryl Yondorf

5:15 PM O-129 POOR SLEEP QUALITY AFTER SURGICAL MENOPAUSE: COMPLEX ASSOCIATIONS BETWEEN MOOD, VASOMOTOR SYMPTOMS, AND MEDICATIONS. Samantha Butts

5:30 PM O-130 THE EFFECT OF SUN EXPOSURE OVER 25-HYDROXYVITAMIN D AND CALCIUM LEVELS IN POSTMENOPAUSAL WOMEN WITH NORMAL BONE DENSITY. A. Bilge Sener-Simsek

5:45 PM O-131 ANXIETY RELATED PHENOTYPES IN A-KINASE ANCHORING PROTEIN 13 (AKAP13) MICE: A POTENTIAL MODEL FOR OBSESSIVE- COMPULSIVE DISORDER. K. Maravet Baig-Ward

6:00 PM O-132 GAPS BETWEEN PHYSICIANS’ PERCEPTIONS OF THE IMPORTANCE OF SHARED DECISION MAKING AND THEIR PRACTICE IN MENOPAUSAL SYMPTOM MANAGEMENT. Sorapop Kiatpongsan

OR02-03 HCC315 MALE REPRODUCTION AND UROLOGY - CLINICAL

4:15 PM O-133 SEXUAL HEALTH IN COMPLETE MALE EPISPADIAS (CME) PATIENTS. Brian Inouye

4:30 PM O-134 MANAGEMENT OF PSYCHOGENIC ANEJACULATION: PRIMARY THERAPY WITH PENILE VIBRATORY STIMULATION (PVS). Gideon Weitzman

4:45 PM O-135 CLOMIPHENE CITRATE IS SUPERIOR TO ANASTRAZOLE IN RAISING TESTOSTERONE IN HYPOGONADAL INFERTILE MEN: A PROSPECTIVE RANDOMIZED DOUBLE BLIND COMPARISON TRIAL.S Helo

5:00 PM O-136 ASSOCIATION BETWEEN TESTOSTERONE THERAPY AND THROMBOTIC EVENTS IN ELDERLY MEN. Ranjith Ramasamy

5:15 PM O-137 WHAT ARE INFERTILITY TREATMENT CENTER WEBSITES TELLING COUPLES ABOUT MALE FACTOR INFERTILITY? Andrew Leung

5:30 PM O-138 AGE DOES MATTER IN SPERM FUNCTION TO ACTIVATE OOCYTES IN SUBFERTILE MEN. Takeshi Shin

OR02-04 HCC303 ENDOMETRIOSIS II

4:15 PM O-139 SIMVASTATIN REDUCES VOLUME OF ACTIVE ENDOMETRIOTIC LESIONS IN PRIMATE MODEL OF ENDOMETRIOSIS. Antoni Duleba

4:30 PM O-140 INVOLVEMENT OF GLUCOSYLCERAMIDES IN ENHANCING ENDOMETRIOTIC ESCS PROLIFERATION. Jerry Chan

4:45 PM O-141 DISCOVERY OF NEW BIOMARKERS FOR ENDOMETRIOSIS. O. Dorien

5:00 PM O-142 THE IMPACT OF ENDOMETRIOSIS ON IVF: AN EVALUATION USING THE SOCIETY OF ASSISTED REPRODUCTIVE TECHNOLOGIES (SART) DATABASE. Suneeta Senapati

5:15 PM O-143 IAP INHIBITOR REPRESSES INFLAMMATION AND THE DEVELOPMENT OF ENDOMETRIOSIS-LIKE LESIONS IN A MURINE MODEL. Fuminori Taniguchi

5:30 PM O-144 NEW BIOMARKERS OF ADENOMYOSIS IN ENDOMETRIUM. Hervé Dechaud

5:45 PM O-145 RADICAL LAPAROSCOPY (LSC) FOR DEEP INFILTRATIVE ENDOMETRIOSIS (DIE) RESTORES PROGESTERONE (P) RESPONSIVENESS IN THE EUTOPIC ENDOMETRIUM (EUE) BY DECREASING MIR-29C AND INCREASING FKBP52. Eduardo Miyadahira

6:00 PM O-146 COMPARISON OF LONG TERM OUTCOMES IN ROBOTIC VERSUS CONVENTIONAL LAPAROSCOPY FOR TREATMENT OF ADVANCED-STAGE ENDOMETRIOSIS: IS THERE ANY DIFFERENCE? ido Sirota

OR02-05 HCC309 CANCER

4:15 PM O-147 COLORECTAL CANCER RISK AFTER OVARIAN STIMULATION FOR IN VITRO FERTILIZATION. Mandy Spaan

4:30 PM O-148 ART AND THE RISK OF CHILDHOOD CANCER - PRELIMINARY RESULTS. Logan Spector

4:45 PM O-149 RISK OF ENDOMETRIAL CANCER AFTER OVARIAN STIMULATION FOR IN-VITRO FERTILIZATION. Alexandra van den Belt-Dusebout

5:00 PM O-150 CANCER TREATMENT NEGATIVELY IMPACTS ANTI-MULLERIAN HORMONE IN PEDIATRIC AND ADOLESCENT FEMALES. Lisa Cookingham

5:15 PM O-151 HIGH INCIDENCE OF TUMORIGENESIS IN THE UMODL1-DEFICIENT OVARIES. Weidong Wang

5:30 PM O-152 CANCER IN WOMEN BEFORE ART. Barbara Luke

5:45 PM O-153 CANCER IN WOMEN AFTER ASSISTED REPRODUCTIVE TECHNOLOGY. Barbara Luke

6:00 PM O-154 MATERNITY AFTER MALIGNANCY: EFFORTS TO PRESERVE FERTILITY, THROUGH OOCYTE CRYOPRESERVATION (OC), IN CANCER PATIENTS OF REPRODUCTIVE AGE. Sarah Druckenmiller

OR02-06 HCC318 EARLY PREGNANCY I

4:15 PM O-155 COST-EFFECTIVENESS ANALYSIS OF PREIMPLANTATION GENETIC SCREENING (PGS) AND IN VITRO FERTILIZATION (IVF) VERSUS EXPECTANT MANAGEMENT IN PATIENTS WITH UNEXPLAINED RECURRENT PREGNANCY LOSS (RPL). Gayathree Murugappan

4:30 PM O-156 RANDOMIZED CLINICAL TRIAL OF PRECONCEPTION LOW DOSE ASPIRIN USE AND PREGNANCY LOSS: RESULTS FROM THE EAGER TRIAL. Sunni Mumford

4:45 PM O-157 SINGLE-NUCLEOTIDE POLYMORPHISM MICROARRAY TESTING (SNP) OF PARAFFIN-EMBEDDED PRODUCTS OF CONCEPTION (PPOC) AS FIRST-LINE ASSESSMENT FOR RECURRENT PREGNANCY LOSS (RPL). Bat-Sheva Maslow

5:00 PM O-158 ASSOCIATION OF ANTI-MULLERIAN HORMONE (AMH) AND LIVE BIRTH: RESULTS FROM THE EFFECTS OF ASPIRIN ON GESTATION AND REPRODUCTION (EAGER) TRIAL. Enrique Schisterman

5:15 PM O-159 MISCARRIAGE RATES IN WOMEN WITH RECURRENT PREGNANCY LOSS AND UNTREATED CHRONIC ENDOMETRITIS. Dana McQueen

5:30 PM O-160 TROPHOBLAST RETRIEVAL AND ISOLATION FROM THE CERVIX (TRIC) TO PREDICT RISK FOR SPONTANEOUS ABORTION. Rani Fritz

5:45 PM O-161 IDENTIFICATION OF EARLY PLACENTAL STEROIDOGENSIS. Robert Setton

6:00 PM O-162 THE EFFECTS OF ENDOMETRIAL INJURY FOR FROZEN-THAWED BLASTOCYST TRANSFER IN HORMONE REPLACEMENT CYCLES. Yukiko Matsumoto

OR02-07 HCC306 OTHER: ART - CLINICAL I

4:15 PM O-163 SHOULD WE PERSIST WITH OVULATION INDUCTION AND INSEMINATION IN WOMEN WITH MALE FACTOR INFERTILITY? Charalampos Chatzicharalampous

4:30 PM O-164 EFFECTIVENESS OF VIDEO-BASED TEACHING IN THE USE OF INJECTABLE FERTILITY MEDICATIONS: A RANDOMIZED CONTROLLED PILOT STUDY. Ankita Patel

4:45 PM O-165 IN VITRO FERTILIZATION (IVF) PATIENTS ONLINE BEHAVIORS: HOW DO THEY BROWSE THE WEB ABOUT INFERTILITY ISSUES AND WHAT ARE THEY LOOKING FOR ONLINE? Alexandra Futeral

5:00 PM O-166 MANY COUPLES STILL DECLINE eSET DESPITE FINANCIAL INCENTIVES: AN UPDATE. Fady Sharara

5:15 PM O-167 INFERTILITY PATIENTS’ MOTIVATIONS FOR AND EXPERIENCES OF CROSS BORDER REPRODUCTIVE SERVICES (CBRS): A PARTIAL TRANS-THEORETICAL MODEL. Steve Lui

5:30 PM O-168 TOWARD A PROGRAM OF SINGLE EMBRYO TRANSFER: REDUCING MULTIPLE GESTATION RISK USING CCS. Philip Chenette

5:45 PM O-169 IMPROVING ICSI OUTCOMES BY ADDING MYO-INOSITOL TO THE SEMEN PREPARATION PROCEDURES: A PROSPECTIVE, RANDOMIZED SIGLE BLIND TRIAL ON SIBLING-OOCYTE. Patrizia Rubino

6:00 PM O-170 AGE-SPECIFIC DROP-OUT RATES FOLLOWING MINIMAL OVARIAN STIMULATION AND NATURAL CYCLE IVF: ANALYSIS OF A 3-YEAR COHORT INVOLVING 2876 TREATMENT CYCLES FROM A SINGLE, JAPANESE CENTER. Satoshi Kawachiya

OR02-08 HCC314 ART OUTCOME PREDICTORS - CLINICAL II

4:15 PM O-171 DON’T WAIT TO FREEZE YOUR EGGS: AS AGE INCREASES SIGNIFICANTLY MORE EGGS ARE NEEDED TO GENERATE A NORMAL EMBRYO. Meredith Brower

4:30 PM O-172 EGG DONATION PRODUCES SIMILAR PREGNANCY RATES WITH THE BLASTOCYST TRANSFER FROM FRESH OR VITRIFIED OOCYTES. Thais Domingues

4:45 PM O-173 CERVICAL CONISATION DOUBLES THE RISK OF PRETERM AND VERY PRETERM DELIVERY IN ART TWINS - NATIONAL CONTROLLED COHORT STURY. Anja Pinborg

5:00 PM O-174 EARLY LUTEAL SERUM LEVELS OF BIOMARKERS ARE PREDICTIVE OF PRETERM DELIVERY (PTD) IN SINGLETON IVF PREGNANCIES. Tomi Kanninen

5:15 PM O-175 SERUM 17-HYDROXYPROGESTERONE (17-OHP) LEVEL ON DAY 7 OF EMBRYO TRANSFER IS A STRONG INDICATOR OF IMPLANTATION AND A RELIABLE MARKER TO DISTINGUISH BETWEEN SINGLETON AND TWIN PREGNANCY IN IVF CYCLES. BINDU Chimote

5:30 PM O-176 TO WHAT EXTENT CAN OOCYTES REPAIR SPERM DNA FRAGMENTATION? Tyler Cozzubbo

5:45 PM O-177 ARE EUPLOIDY RATES DIFFERENT IN BLASTOCYSTS FROM DONOR OOCYTES AND THOSE FROM YOUNG INFERTILE PATIENTS? Mina Alikani

6:00 PM O-178 BLASTOCYSTS AVAILABLE FOR BIOPSY ON DAY 5 ARE MORE LIKELY TO RESULT IN A VIABLE PREGNANCY. Oleksii Barash

OR02-09 HCC301 ART OUTCOME PREDICTORS - LAB I

4:15 PM O-179 CELL-FREE DNA IN HUMAN FOLLICULAR FLUID AS NEW NON-INVASIVE BIOMARKER OF EMBYO QUALITY. Elodie Scalici

4:30 PM O-180 ASSESSING THE EFFECTS OF VITRIFICATION ON EMBRYO VIABILITY USING LABEL-FREE IMAGING. Livia Zarnescu

4:45 PM O-181 THE EFFECT OF INNER CELL MASS SIZE ON THE OUTCOME OF SINGLE-BLASTOCYST TRANSFERS. Bruce Shapiro

5:00 PM O-182 ASSESSING MORPHOKINETIC PARAMETERS AS FRACTIONS OF THE TIME TO FULL BLASTOCELE TO PREDICT EUPLOIDY: TESTING A MORE SENSITIVE MEASUREMENT METHOD. Yael Kramer

5:15 PM O-183 BLASTOCYST EXPANSION AND INNER CELL MASS GRADES ARE ASSOCIATED WITH CLINICAL PREGNANCY IN FRESH SINGLE TRANSFERS. Jessica Subira

5:30 PM O-184 ANTIMULLERIAN HORMONE DOES NOT PREDICT OUTCOME OF PREIMPLANTATION GENETIC SCREENING. Amanda Bostian

5:45 PM O-185 MORPHOKINETICS OF EMBRYOS OBTAINED WITH NORMAL EJACULATED SPERM OR WITH TESTICULAR SPERM FROM NOA PATIENTS. Maria Giulia Minasi

6:00 PM O-186 FREQUENCY OF THE 919G>A, 2039A>G, and -29 (G/A) SINGLE-NUCLEOTIDE POLYMORPHISMS (SNPs) IN THE FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) GENE IN MEXICAN MESTIZO WOMEN. Gabriela García

OR02-10 HCC317 OVARIAN STIMULATION - POOR RESPONDERS

4:15 PM O-187 IMPORTANCE OF POSTPRANDIAL GLYCEMIA (PPG) IN ART: A NOVEL THERAPY WITH SITAGLIPTIN FOR ART REPEATERS INCREASES PREGNANCY RATE BY DECREASING PPG AND ADVANCED GLYCATION ENDPRODUCTS. Masao Jinno

4:30 PM O-188 DOUBLE STIMULATIONS DURING THE FOLLICULAR AND LUTEAL PHASES IN PATIENTS WITH POOR OVARIAN RESPONSE IN IVF/ICSI PROGRAMS (THE SHANGHAI PROTOCOL). Yanping Kuang

4:45 PM O-189 DOES EXOGENOUS LH SUPPLEMENTATION IMPROVE REPRODUCTIVE OUTCOME IN POOR RESPONDER WOMEN UNDERGOING IVF/ICSI IN GNRH ANTAGONIST PROTOCOL. KANAD Nayar

5:00 PM O-190 EFFICACY OF CLOMIPHENE CITRATE SUPPLEMENTATION TO CONVENTIONAL GNRH ANTAGONIST PROTOCOLS IN POOR RESPONDERS UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY – A PROSPECTIVE RANDOMIZED TRIAL. Akihisa Fujimoto

5:15 PM O-191 TREATMENT OF AROMATASE INHIBITORS IN SEVERE POOR RESPONDER PATIENTS: MATCHED COMPARISON WITH NON-TREATED PREVIOUS CYCLES IN SAME PATIENTS. M. K. Chung

5:30 PM O-192 A COMPARISON OF TWO OVARIAN STIMULATION PROTOCOLS FOR POOR RESPONDERS UNDERGOING IVF. Michal Youngster

5:45 PM O-193 IMPACT OF LEAD FOLLICLE SIZE IN CLOMIPHENE CITRATE-ONLY MINIMAL STIMULATION IN-VITRO FERTILIZATION (IVF) CYCLES. Lindsay Kroener

6:00 PM O-194 IN VITRO FERTILIZATION POOR RESPONDERS: IS INTRAUTERINE INSEMINATION BETTER THAN OOCYTE RETRIEVAL? Dianna Gurich

OR02-11 HCC304 MALE FACTOR I

4:15 PM O-195 TRENDS IN THE USE OF ICSI: INDICATIONS AND PREGNANCY OUTCOMES, UNITED STATES 1996-2011. Sheree Boulet

4:30 PM O-196 EFFECT OF SPERM DNA FRAGMENTATION ON IVF/ICSI CLINICAL OUTCOMES IS DIVERSIFIED IN WOMEN WITH DIFFERENT OVARIAN RESERVE. Jianyuan Jin

4:45 PM O-197 HUMAN SEX RATIO AND NUMERICAL CHROMOSOME ABNORMALITIES IN SPERMATOZOA SELECTED USING MOTILE SPERM ORGANELLE MORPHOLOGY EXAMINATION (MSOME). Claudia Petersen

5:00 PM O-198 SPERM FLUORESCENCE IN SITU HYBRIDIZATION ANALYSIS OF AZFc MICRODELETION IN SEVERE OLIGOZOOSPERMIA. XiaoBin Zhu

5:15 PM O-199 COMPARISON OF ART OUTCOME BETWEEN NON-OBSTRUCTIVE AZOOSPERMIA AND OBSTRUCTIVE AZOOSPERMIA: 15 YEARS EXPERIENCES. Atsumi Yoshida

5:30 PM O-200 IDENTIFICATION OF IL-7R AS A CANDIDATE PROTEOMIC MARKER FOR ASTHENOZOOSPERMIA BY HIGH THROUGHPUT SCREENING (HTS) OF HUMAN SPERMATOZOA. Ekaterina Shlush

5:45 PM O-201 THE ASSESSMENT OF FERTILIZATION AND EMBRYONIC DEVELOPMENT USING TESTICULAR SPERMATOZOA AMONG PRESUMED HISTOPATHOLOGY IN TESTICULAR BIOPSY FROM NON-OBSTRUCTIVE AZOOSPERMIA (NOA). Shimpei Mizuta

6:00 PM O-202 ASSESSMENT OF SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY (SART) FERTILITY CLINIC WEBSITES FOR MALE INFERTILITY INFORMATION AND RESOURCES. Samantha Schon

OR02-12 HCC308 REPRODUCTIVE BIOLOGY - RESEARCH

4:15 PM O-203 EXPLORING NEW MORPHOKINETIC VARIABLES OF IN VITRO AND IN VIVO EMBRYO DEVELOPMENT. Maria Jose Escriba

4:30 PM O-204 RELATION OF SPERM METHYLATION ABNORMALITY TO MISCARRIAGE VILLUS METHYLATION ABNORMALITY. Akiko Sato

4:45 PM O-205 THE EFFECT OF AGE ON IMPLEMENTING ONLY VITRIFIED BLASTOCYST TRANSFER (VFBT) CYCLES AND THE USE OF EUPLOID BLASTOCYSTS (BL) TO OPTIMIZE IMPLANTATION AND SINGLE EMBRYO TRANSFER (SET). John Whitney

5:00 PM O-206 EFFECT OF BENCHTOP INCUBATORS WITH LOWERED OXYGEN CONCENTRATION ON FERTILIZATION AND PREIMPLANTATION EMBRYO DEVELOPMENT: A RANDOMIZED CONTROLLED TRIAL USING SIBLING OOCYTES. Michael Steinkampf

5:15 PM O-207 ABNORMALLY-CLEAVED EMBRYOS AT 1ST OR 2ND CLEAVAGE HAD LOW DEVELOPMENTAL POTENTIAL. Takaaki Sekitoh

5:30 PM O-208 THE SOURCE OF OOCYTES, FRESH OR VITRIFIED, DOES NOT AFFECT IMPLANTATION POTENTIAL BASED ON KINETIC MARKERS. Marina Aragonés

5:45 PM O-209 DAY 3 EMBRYO METABOLOMICS IN THE SPENT CULTURE MEDIA IS ALTERED IN OBESE WOMEN UNDERGOING IVF. JOSE Bellver

6:00 PM O-210 FREEZE ALL POLICY: FRESH VERSUS ELECTIVE FROZEN-THAWED EMBRYO TRANSFER. Matheus Roque

OR02-13 HCC312 REPRODUCTIVE SURGERY

4:15 PM O-211 OVARIAN TRANSPLANTATION AND MECHANISM FOR RESTING FOLLICLE RECRUITMENT. Sherman Silber

4:30 PM O-212 OVARIAN LESIONS VOLUMES AS A SCREEN FOR MALIGNANCY IN PEDIATRIC OVARIAN TUMORS. P. Abbas

4:45 PM O-213 THE IN-VIVO EFFECTS OF SUPEROXIDE DISMUTASE ON THE INCIDENCE AND SEVERITY OF POST-OPERATIVE ADHESION DEVELOPMENT. Awoniyi Awonuga

5:00 PM O-214 DIGITAL CAMERA BASED OFFICE HYSTEROSCOPY. Federico Casabona

5:15 PM O-215 ENDOMETRIAL SCRATCHING IMPROVES PREGNANCY RATES IN RECCURENT IVF FAILURE. Batuhan Ozmen

5:30 PM O-216 LAPAROSCOPIC SURGERY FOR DISTAL TUBAL OCCLUSIONS: LESSONS LEARNED FROM A HISTORICAL SERIES OF 434 CASES. Alain Audebert

5:45 PM O-217 LONG-TERM FERTILITY AND BLEEDING OUTCOMES AFTER ROBOTIC, LAPAROSCOPIC, AND ABDOMINAL MYOMECTOMY. Rebecca Flyckt

6:00 PM O-218 SURGICAL PAIN CONTROL WITH ROPIVACAINE BY ATOMIZED DELIVERY (SPRAY): A RANDOMIZED CONTROLLED TRIAL. Gretchen Collins

ASRM MEMBERSHIP

View Details
Learn More | Join | Renew
Back to Top